A prevalent CTLA4 missense variant significantly associates with inhibitor development in Argentine patients with severe haemophilia A

Haemophilia. 2017 Mar;23(2):e166-e169. doi: 10.1111/hae.13194. Epub 2017 Feb 20.
No abstract available

Publication types

  • Letter

MeSH terms

  • Argentina
  • CTLA-4 Antigen / genetics*
  • Factor VIII / immunology
  • Genotype
  • Hemophilia A / drug therapy
  • Hemophilia A / genetics*
  • Hemophilia A / immunology*
  • Humans
  • Mutation, Missense*

Substances

  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Factor VIII